Hyfe

In September, we had the pleasure of hosting the 8th Hyfe's Cough Science Forum featuring 3 expert speakers introducing their work and progress in the field of cough science - Dr. Jane Reynolds, Dr. Marc Judson and Dr. Carlos Chaccour. You can access the meeting recording below ????

New White Paper: Exploring Heart Rate and Cough Severity Our latest white paper looks at how heart rate changes during coughing can offer new ways to monitor health. By combining heart and respiratory data, we can better understand the impact of coughing on the body, especially for people with chronic conditions. Find the link to the white paper in the comments below ????

It is wonderful to participate in RESCON 2024 - the premier meeting about connected inhalation drug delivery devices. Cough is so relevant to the disease getting these therapies - both a prominent symptom and potential adverse drug effect! Our CMO Dr. Peter Small just gave a talk at the #RESCON Summit in New York, titled 'Cough Science: Novel Insights From AI-Enabled Monitoring'. Would you be interested to learn more about the evidence of cough as a biomarker in asthma, COPD, Cystic Fibrosis, among other conditions? Comment "cough" and we'll send you an evidence-based overview! #Cough #AI #DigitalHealth #RespiratoryHealth #Innovation

Find CoughPro at https://coughpro.com/ ??

Cough: New Therapies (in refractory chronic cough, IPF and DTx) European Respiratory Society hosted an ERS Vision Live panel discussion on new cough therapies, moderated by Prof. Surinder Birring and Dr. Jacky Smith. Expert panelists Dr. Imran Satia, Dr. Slovarp Laurie and Prof. Marlies Wijsenbeek-Lourens discussed: - Emerging drug classes for refractory chronic cough - Speech and language therapy interventions for chronic cough - Cough and idiopathic pulmonary fibrosis (IPF) Of particular interest was the potential of a novel digital therapeutic (DTx) for chronic cough, based on cognitive behavioural cough suppression techniques. Non-invasive, accessible, and affordable, such DTx solutions could either serve as alternatives to drug treatments or complement emerging pharmacotherapies. Prof. Marlies Wijsenbeek-Lourens also underscored the need for standardized cough measurement and interpretation across therapeutic areas, emphasizing, “we need to be unifying the way we measure cough.” This aligns with discussions at the IPF Summit in Boston this summer, where experts emphasized that “cough is a sleeper biomarker in IPF.” With continuous cough monitoring technologies now available, there is a timely opportunity to explore the value of cough as a biomarker: predictive, prognostic, indicative of treatment response, among other... #Cough #Biomarker #IPF #ChronicCough #DigitalTherapeutics #DTx

Promising results and progress in chronic cough treatment Sensory Cloud, Inc. and Hyfe announced promising results from a study showing that Sensory Cloud’s inhaled alkaline HDS aerosol significantly reduced cough frequency in patients with refractory chronic cough (RCC), with no significant adverse events. Cough counts were measured continuously using Hyfe’s AI-powered technology. Read more ?? https://lnkd.in/gmGV3fP5

To support the development of an accurate, point-of-care cough-based triage tool for TB, we have compiled a large multi-country database of cough sounds from individuals being evaluated for TB. The dataset includes more than 700,000 cough sounds from 2,143 individuals with detailed demographic, clinical and microbiologic diagnostic information. We aim to empower researchers in the development of cough sound analysis models to improve TB diagnosis, where innovative approaches are critically needed to end this long-standing pandemic. ?? Link in the comments

AI-based analysis of cough sounds has the potential to transform the diagnosis and management of tuberculosis in low-resource settings. I'm so proud of Hyfe for our involvement in creating this open and free dataset of 700,000 cough sounds from 2,143 individuals across seven countries, to enable more research in this area cc Simon Grandjean Lapierre https://lnkd.in/dVG2JsxR

?? New Publication Using an earlier version of Hyfe's cough monitoring technology, this research demonstrates the feasibility of community-based cough monitoring in low-resource settings. As we look back, it's remarkable to see how far and fast we've come. Technical innovation now makes this level of health monitoring at scale a reality, paving the way for scalable solutions in Global Health. Find the link to the publication in the comments #globalhealth #tbcare #cough #coughmonitoring

?? 7-day continuous cough monitoring outperforms 24-hour methods ?? This latest Hyfe white paper presents data-driven evidence showing how prolonged monitoring provides more reliable insights for clinical trials and research studies, offering a new standard for understanding cough variability. ?? Find the link in the comments